首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.
【2h】

Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.

机译:低密度脂蛋白受体的第一个富含半胱氨酸的重复序列的缺失会损害其运输但不会损害家族性高胆固醇血症患者成纤维细胞中脂蛋白的结合。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The ligand-binding domain of the low density lipoprotein (LDL) receptor is composed of seven cysteine-rich repeats, each approximately 40 amino acids long. Previous studies by van Driel et al. [van Driel, I. R., Goldstein, J. L., Sudhof, T. C. & Brown, M. S. (1987) J. Biol. Chem. 262, 17443-17449] showed that if the first repeat of the ligand-binding domain (encoded by exon 2) is deleted, the receptor fails to bind an anti-LDL receptor monoclonal antibody (IgG-C7) but continues to bind LDL with high affinity. Cultured fibroblasts from a Black South African Xhosa patient (TT) with the clinical syndrome of homozygous familial hypercholesterolemia demonstrated high-affinity cell-surface binding of 125I-labeled LDL but not 125I-labeled IgG-C7. Previous haplotype analysis, using 10 restriction fragment length polymorphic sites, suggested that the patient inherited two identical LDL receptor alleles. The polymerase chain reaction technique was used to selectively amplify exon 2 of the LDL receptor gene from this patient. Sequence analysis of the amplified fragment disclosed a deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat. The mutation creates a new PstI restriction site that can be used to detect the deletion. The existence of this mutant allele confirms that the epitope of IgG-C7 is located in the first cysteine-rich repeat and that this repeat is not necessary for LDL binding. The mutant gene produced a normally sized 120-kilodalton LDL receptor precursor protein that matured to the 160-kilodalton form at less than one-fourth the normal rate. Thus, deletion of two amino acids within the first cysteine-rich repeat retards receptor transport from the endoplasmic reticulum to the cell surface, in contrast to deletion of the entire first repeat, which has no effect on receptor maturation.
机译:低密度脂蛋白(LDL)受体的配体结合结构域由七个富含半胱氨酸的重复序列组成,每个重复序列大约40个氨基酸长。 van Driel等人先前的研究。 [van Driel,I. R.,Goldstein,J. L.,Sudhof,T. C.&Brown,M. S.(1987)J. Biol。化学[262,17443-17449]显示,如果缺失了配体结合结构域的第一个重复序列(由外显子2编码),受体将无法结合抗LDL受体单克隆抗体(IgG-C7),但会继续与LDL结合高亲和力。来自患有纯合子家族性高胆固醇血症临床症状的南非黑人科萨人(TT)的培养成纤维细胞显示出125I标记的LDL而非125I标记的IgG-C7的高亲和力细胞表面结合。先前使用10个限制性片段长度多态性位点进行的单倍型分析表明,该患者遗传了两个相同的LDL受体等位基因。聚合酶链反应技术用于选择性扩增该患者的LDL受体基因的外显子2。扩增片段的序列分析揭示了六个碱基对的缺失,该碱基对从第一个富含半胱氨酸的配体结合重复序列中删除了两个氨基酸,天冬氨酸和甘氨酸。该突变产生了一个新的PstI限制性酶切位点,可用于检测缺失。该突变等位基因的存在证实了IgG-C7的表位位于第一个富含半胱氨酸的重复序列中,并且该重复序列对于LDL结合不是必需的。突变基因产生了正常大小的120公斤LDL受体前体蛋白,该蛋白以不到正常速度的四分之一成熟为160公斤形式。因此,与整个第一重复序列的缺失相反,缺失第一富含半胱氨酸的重复序列内的两个氨基酸阻碍了受体从内质网向细胞表面的转运,这对受体的成熟没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号